These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21062759)

  • 1. From peptides to proteins: lessons from my years at the Centre for Protein Engineering.
    Friedler A
    Protein Eng Des Sel; 2011 Jan; 24(1-2):241-5. PubMed ID: 21062759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of protein-protein interactions for p53 function: the CPE contribution.
    Fernandez-Fernandez MR; Sot B
    Protein Eng Des Sel; 2011 Jan; 24(1-2):41-51. PubMed ID: 20952436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-peptide interactions adopt the same structural motifs as monomeric protein folds.
    Vanhee P; Stricher F; Baeten L; Verschueren E; Lenaerts T; Serrano L; Rousseau F; Schymkowitz J
    Structure; 2009 Aug; 17(8):1128-36. PubMed ID: 19679090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using peptides to study protein-protein interactions.
    Benyamini H; Friedler A
    Future Med Chem; 2010 Jun; 2(6):989-1003. PubMed ID: 21426115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
    Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
    Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
    Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering novel binding proteins from nonimmunoglobulin domains.
    Binz HK; Amstutz P; Plückthun A
    Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion NMR spectroscopy: folding and aggregation of domains in p53.
    Dehner A; Kessler H
    Chembiochem; 2005 Sep; 6(9):1550-65. PubMed ID: 16138303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins--identification of additional interacting regions.
    Iosefson O; Azem A
    FEBS Lett; 2010 Mar; 584(6):1080-4. PubMed ID: 20153329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis.
    Guo Z; Mohanty U; Noehre J; Sawyer TK; Sherman W; Krilov G
    Chem Biol Drug Des; 2010 Apr; 75(4):348-59. PubMed ID: 20331649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer models of protein stability, folding, and interactions.
    Zhou HX
    Biochemistry; 2004 Mar; 43(8):2141-54. PubMed ID: 14979710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique complex between bacterial azurin and tumor-suppressor protein p53.
    Apiyo D; Wittung-Stafshede P
    Biochem Biophys Res Commun; 2005 Jul; 332(4):965-8. PubMed ID: 15913547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.
    Ma B; Pan Y; Gunasekaran K; Keskin O; Venkataraghavan RB; Levine AJ; Nussinov R
    Phys Biol; 2005 Jun; 2(2):S56-66. PubMed ID: 16204849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53--insights into a complex process.
    Boehme KA; Blattner C
    Crit Rev Biochem Mol Biol; 2009; 44(6):367-92. PubMed ID: 19929178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide binding proteins: what remains to be discovered?
    Fischer G; Wawra S
    Mol Microbiol; 2006 Sep; 61(6):1388-96. PubMed ID: 16930150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
    Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
    Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational stability and folding mechanisms of dimeric proteins.
    Rumfeldt JA; Galvagnion C; Vassall KA; Meiering EM
    Prog Biophys Mol Biol; 2008 Sep; 98(1):61-84. PubMed ID: 18602415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding a de novo designed peptide into an alpha-helix through hydrophobic binding by a bowl-shaped host.
    Tashiro S; Tominaga M; Yamaguchi Y; Kato K; Fujita M
    Angew Chem Int Ed Engl; 2005 Dec; 45(2):241-4. PubMed ID: 16312001
    [No Abstract]   [Full Text] [Related]  

  • 19. Engineering modular protein interaction switches by sequence overlap.
    Sallee NA; Yeh BJ; Lim WA
    J Am Chem Soc; 2007 Apr; 129(15):4606-11. PubMed ID: 17381089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.
    De Grandis V; Bizzarri AR; Cannistraro S
    J Mol Recognit; 2007; 20(4):215-26. PubMed ID: 17703463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.